Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
"Putting One Foot in Front of the Other": A Qualitative Study of Emotional Experiences and Help-Seeking in Women with Multiple Sclerosis.
Endocannabinoids and neurodegenerative diseases.
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10.
Including known covariates can reduce power to detect genetic effects in case-control studies.
The next generation of exoskeletons: lighter, cheaper devices are in the works.
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
Modeling the heterogeneity of multiple sclerosis in animals.
Mobile phones and multiple sclerosis - a nationwide cohort study in denmark.
A touch of MS: Therapeutic mislabeling.
Sativex(®) in multiple sclerosis spasticity: a cost-effectiveness model.
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Multiple sclerosis.
Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis.
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.
Right Under Our Noses: Olfactory Pathology In Central Nervous System Demyelinating Diseases
Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer.
Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod.
European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil.
The Role of Demyelination in Neuromyelitis Optica Damage: Diffusion-Tensor MR Imaging Study.
Overview of the biology of type I interferons.
Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus.
Using a highly abbreviated California Verbal Learning Test-II to detect verbal memory deficits.
Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Pages
« first
‹ previous
…
188
189
190
191
192
193
194
195
196
…
next ›
last »